LCTX
Lineage Cell Therapeutics Inc
0.9274$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 13.6% | 20.6% | 18.9% | 3.1% | 1.0% | 5.4% | 2.4% | 1.4% | 0.1% | 1.0% | 10.9% | 17.5% | 3.4% | |
| 86.4% | 79.4% | 81.1% | 96.9% | 99.0% | 94.6% | 97.6% | 98.6% | 99.9% | 99.0% | 89.1% | 82.5% | 96.6% | |
| 300.2% | 185.5% | 206.9% | 203.7% | 83.9% | 119.4% | 207.3% | 112.3% | 88.9% | 124.7% | 245.4% | 446.6% | 156.8% | |
| 324.3% | 205.4% | 346.1% | 309.9% | 116.7% | 153.5% | 323.4% | 164.9% | 113.9% | 73.4% | 294.7% | 488.1% | 147.9% | |
| 624.6% | 384.1% | 542.4% | 513.6% | 200.6% | 272.8% | 530.7% | 814.0% | 202.7% | 198.1% | 529.3% | 917.2% | 301.8% | |
| -538.1% | -304.7% | -461.3% | -416.7% | -101.6% | -178.2% | -433.1% | -715.4% | -102.9% | -99.1% | -440.2% | -834.7% | -205.2% | |
| – | 20.8% | – | – | – | – | – | – | – | – | – | – | – | |
| -574.5% | -225.8% | -454.2% | -410.0% | -79.4% | -113.3% | -275.8% | -1,098.2% | -808.3% | -66.4% | -277.6% | 144.4% | -285.8% | |
| -3.9% | 2.9% | -1.1% | -0.9% | 0.9% | 0.3% | – | – | – | -79.9% | – | – | – | |
| -570.6% | -228.7% | -453.0% | -409.1% | -80.3% | -114.1% | -275.6% | -1,101.8% | -809.0% | 12.9% | -279.0% | 138.6% | -246.6% | |
| -560.4% | -217.4% | -442.0% | -399.9% | -75.7% | -108.1% | -264.9% | -172.5% | -803.4% | -63.6% | -266.7% | 161.9% | -280.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.